Comparison of Intubation Rate of Macintosh Size 2 and 3 Blades in Asian Female: a Randomised Controlled Trial
Launched by MACKAY MEMORIAL HOSPITAL · Sep 22, 2020
Trial Information
Current as of May 11, 2025
Completed
Keywords
ClinConnect Summary
Selection the most appropriate size of laryngoscope blade size could not only increased intubation successful rate at the first time but also decrease the incidence of tissue trauma. Laryngoscope blade used in daily practice is usually Macintosh 3. However, compared with Caucasian people, Asian people are smaller and thinner especially in women. This study aims to confirm that the Macintosh 2 blade is not inferior to size 3 blade in laryngeal view and intubation rate.
Female patients without known difficult airway will be enrolled and allocated into Macintosh blade size 2 and size 3 groups...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • with American Society of Anesthesiologists (ASA) physical status classification 1, 2, or 3
- • undergo elective surgery
- • receive endotracheal intubation
- Exclusion Criteria:
- • with known difficult airway (i.e. pathology of the neck, upper airway or alimentary tracts)
- • with risks of pulmonary aspiration (i.e. emergent operation, pregnancy or inadequate nil per os)
- • with previous difficult intubation history
- • intubation attempts more than three times
- • patient refusal
About Mackay Memorial Hospital
Mackay Memorial Hospital is a leading healthcare institution dedicated to advancing medical science through innovative clinical research. With a commitment to patient-centered care, the hospital actively sponsors and conducts clinical trials across various therapeutic areas, aiming to develop new treatment options and improve health outcomes. Boasting a team of experienced researchers and healthcare professionals, Mackay Memorial Hospital adheres to rigorous ethical standards and regulatory guidelines, ensuring the safety and well-being of participants while contributing to the global body of medical knowledge. Its collaborative approach fosters partnerships with academic institutions and industry leaders, positioning it as a key player in the advancement of healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei, , Taiwan
Patients applied
Trial Officials
Nuan-Yen Su, MS
Study Director
Mackay Memorial hospital, department of anesthesiology, attending physician
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials